content

Safe And Efficient Gene Editing With Virus-Derived Peptides

A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as...

Complexity of APIs Drive OSD Contract Manufacturing Demand

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient...

FDA Releases Draft Guidance On Decentralized Clinical Trials

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials...

Digital Bioprocessing Is Set To Improve Drug Product Quality

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11%...

European Medicines Agency recommends bimekizumab in two new indications

UCB, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued...

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

Recipharm, a Global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US FDA...

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) Software for clinical trials, has launched registration for RBQM Live...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read